Euro surveillance : bulletin européen sur les maladies transmissibles, 2018-03, Vol.23 (9)
2018
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
- Ist Teil von
- Euro surveillance : bulletin européen sur les maladies transmissibles, 2018-03, Vol.23 (9)
- Ort / Verlag
- Sweden: Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)
- Erscheinungsjahr
- 2018
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1560-7917, 1025-496XeISSN: 1560-7917, 1025-496XDOI: 10.2807/1560-7917.ES.2018.23.9.18-00086Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5840921
- Format
- –
- Schlagworte
- Adolescent, Adult, Aged, Child, Child, Preschool, Effectiveness studies, Europe - epidemiology, European Union, Female, Human health and pathology, Humans, Immunization, Immunology, Infant, Infant, Newborn, Infectious diseases, Influenza, Influenza A Virus, H1N1 Subtype - immunology, Influenza A Virus, H1N1 Subtype - isolation & purification, Influenza A Virus, H3N2 Subtype - immunology, Influenza A Virus, H3N2 Subtype - isolation & purification, Influenza B virus - immunology, Influenza B virus - isolation & purification, Influenza Vaccines - administration & dosage, Influenza Vaccines - adverse effects, Influenza Vaccines - immunology, Influenza Vaccines - therapeutic use, Influenza, Human - epidemiology, Influenza, Human - prevention & control, Influenza, Human - virology, Life Sciences, Male, Middle Aged, Pandemics - prevention & control, Public health, Rapid Communication, Santé publique et épidémiologie, Seasons, Treatment Outcome, Vaccination - statistics & numerical data, Vaccines, Vaccinology